Chlorhexidine Gluconate and Calcium Lactobionate are often combined to provide antimicrobial protection and promote wound healing in various clinical applications. Chlorhexidine, a broad-spectrum antiseptic, effectively eliminates bacteria and fungi, while Calcium Lactobionate supports tissue repair by replenishing essential calcium ions. Chlorhexidine Gluconate was first approved by the FDA in 1984 for oral rinse and topical use, while Calcium Lactobionate has been used in healthcare settings to address calcium deficiencies and promote healing. Clinical trials have demonstrated the efficacy of this combination in preventing infections and enhancing recovery in surgical wounds and dental procedures.

• Prevention of infection in minor cuts, wounds, and burns
• Oral rinse for managing gingivitis and plaque
• Antiseptic for pre-surgical skin preparation
• Calcium supplementation to prevent deficiency in clinical settings
• Support for wound healing in dental and surgical applications

Chlorhexidine Gluconate is commonly used as an oral rinse, topical solution, or gel for dental and skin applications. It is usually prescribed in a 0.12% concentration, with a recommended dosage of 15 mL twice daily for oral rinses. Topical solutions are applied directly to the skin for antiseptic purposes. Calcium Lactobionate, administered intravenously, is primarily used to treat calcium deficiency in critically ill patients. Dosage is adjusted based on the severity of calcium deficiency and patient-specific factors. Healthcare providers carefully monitor calcium levels during administration to prevent complications.

Common Side Effects:

• Tooth staining and altered taste (Chlorhexidine)
• Mild skin irritation or burning sensation
• Gastrointestinal discomfort (Calcium Lactobionate)
• Flushing and warmth during intravenous administration

Serious Side Effects:

• Hypersensitivity reactions, including rash, itching, and swelling
• Severe allergic responses such as anaphylaxis
• Hypercalcemia with prolonged calcium administration
• Arrhythmias and cardiac complications in patients with renal dysfunction

• Avoid ingestion of Chlorhexidine oral rinse to prevent gastrointestinal discomfort.
• Contraindicated in patients with hypersensitivity to Chlorhexidine or calcium derivatives.
• Avoid combining with anionic surfactants, as they reduce the efficacy of Chlorhexidine.
• Use with caution in patients with renal impairment when administering Calcium Lactobionate.
• Prolonged use may cause tooth staining or alter taste perception.

Patients using Chlorhexidine oral rinse should avoid rinsing with water immediately after use, as it may dilute the antiseptic effect. Long-term use may lead to staining of teeth, dental restorations, and the tongue. Calcium Lactobionate should be administered with caution in patients with renal impairment or hypercalcemia, as excess calcium may lead to cardiac arrhythmias. Careful monitoring of serum calcium levels is necessary in critically ill patients receiving calcium supplementation.

For best results, use Chlorhexidine oral rinse as directed without rinsing immediately after application. Monitor for signs of irritation or allergic reactions, especially with long-term use. When receiving intravenous Calcium Lactobionate, patients should be closely monitored for serum calcium levels to avoid hypercalcemia. Inform healthcare providers about any history of kidney disease or allergies before using these medications.

1. https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-drug-safety-podcast-fda-warns-about-rare-serious-allergic-reactions-skin-antiseptic
2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020774Orig1s010lbl.pdf
3. https://www.drugs.com/monograph/chlorhexidine-gluconate-topical.html
4. https://pubchem.ncbi.nlm.nih.gov/compound/Calcium-Lactobionate

The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice. Consult your healthcare provider before starting or stopping any medication.